Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
A Response to: Letter to the Editor Regarding “Aflibercept 8 mg Versus Faricimab Treat-and-Extend for Diabetic Macular Edema or Neovascular Age-Related Macular Degeneration: A Bayesian Fixed-Effect Network Meta-analysis of Clinical Trials”
Saved in:
| Published in: | Ophthalmology and Therapy |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1870478482324062208 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | Ophthalmology and Therapy |
| description | |
| discipline_display | Ophthalmology and Optometry |
| discipline_facet | Ophthalmology and Optometry |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:102096 |
| institution | FRELIP |
| journal_source_facet | Ophthalmology and Therapy |
| last_indexed | 2026-07-12T03:34:47.673Z |
| publishDate | 2026 |
| publishDateSort | 2026 |
| record_format | rss_article |
| spellingShingle | A Response to: Letter to the Editor Regarding “Aflibercept 8 mg Versus Faricimab Treat-and-Extend for Diabetic Macular Edema or Neovascular Age-Related Macular Degeneration: A Bayesian Fixed-Effect Network Meta-analysis of Clinical Trials” Ophthalmology and Optometry General Ophthalmology and Optometry |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Ophthalmology and Optometry General Ophthalmology and Optometry |
| subject_facet | Ophthalmology and Optometry General Ophthalmology and Optometry |
| title | A Response to: Letter to the Editor Regarding “Aflibercept 8 mg Versus Faricimab Treat-and-Extend for Diabetic Macular Edema or Neovascular Age-Related Macular Degeneration: A Bayesian Fixed-Effect Network Meta-analysis of Clinical Trials” |
| title_alt | Respuesta a: Carta al Editor sobre “Aflibercept 8 mg Versus Faricimab Treat-and-Extend para edema macular diabético o degeneración macular neovascular relacionada con la edad: Un metaanálisis de red bayesiano de efectos fijos de ensayos clínicos” Réponse à la lettre à l'éditeur concernant « Aflibercept 8 mg versus Faricimab en treat-and-extend pour l'œdème maculaire diabétique ou la dégénérescence maculaire néovasculaire liée à l'âge : une méta-analyse en réseau bayésienne à effets fixes d'essais cliniques » Resposta à: Carta ao Editor sobre “Aflibercept 8 mg Versus Faricimab Tratar-e-Estender para Edema Macular Diabético ou Degeneração Macular Neovascular Relacionada à Idade: Uma Meta-análise de Rede Bayesiana de Efeito Fixo de Ensaios Clínicos” |
| title_auth | A Response to: Letter to the Editor Regarding “Aflibercept 8 mg Versus Faricimab Treat-and-Extend for Diabetic Macular Edema or Neovascular Age-Related Macular Degeneration: A Bayesian Fixed-Effect Network Meta-analysis of Clinical Trials” |
| title_es_txt | Respuesta a: Carta al Editor sobre “Aflibercept 8 mg Versus Faricimab Treat-and-Extend para edema macular diabético o degeneración macular neovascular relacionada con la edad: Un metaanálisis de red bayesiano de efectos fijos de ensayos clínicos” |
| title_fr_txt | Réponse à la lettre à l'éditeur concernant « Aflibercept 8 mg versus Faricimab en treat-and-extend pour l'œdème maculaire diabétique ou la dégénérescence maculaire néovasculaire liée à l'âge : une méta-analyse en réseau bayésienne à effets fixes d'essais cliniques » |
| title_full | A Response to: Letter to the Editor Regarding “Aflibercept 8 mg Versus Faricimab Treat-and-Extend for Diabetic Macular Edema or Neovascular Age-Related Macular Degeneration: A Bayesian Fixed-Effect Network Meta-analysis of Clinical Trials” |
| title_fullStr | A Response to: Letter to the Editor Regarding “Aflibercept 8 mg Versus Faricimab Treat-and-Extend for Diabetic Macular Edema or Neovascular Age-Related Macular Degeneration: A Bayesian Fixed-Effect Network Meta-analysis of Clinical Trials” |
| title_full_unstemmed | A Response to: Letter to the Editor Regarding “Aflibercept 8 mg Versus Faricimab Treat-and-Extend for Diabetic Macular Edema or Neovascular Age-Related Macular Degeneration: A Bayesian Fixed-Effect Network Meta-analysis of Clinical Trials” |
| title_pt_txt | Resposta à: Carta ao Editor sobre “Aflibercept 8 mg Versus Faricimab Tratar-e-Estender para Edema Macular Diabético ou Degeneração Macular Neovascular Relacionada à Idade: Uma Meta-análise de Rede Bayesiana de Efeito Fixo de Ensaios Clínicos” |
| title_short | A Response to: Letter to the Editor Regarding “Aflibercept 8 mg Versus Faricimab Treat-and-Extend for Diabetic Macular Edema or Neovascular Age-Related Macular Degeneration: A Bayesian Fixed-Effect Network Meta-analysis of Clinical Trials” |
| title_sort | a response to: letter to the editor regarding “aflibercept 8 mg versus faricimab treat-and-extend for diabetic macular edema or neovascular age-related macular degeneration: a bayesian fixed-effect network meta-analysis of clinical trials” |
| topic | Ophthalmology and Optometry General Ophthalmology and Optometry |
| url | https://link.springer.com/article/10.1007/s40123-026-01439-5 |